HAL (France)open access
A novel stilbene derivative targets RAD51 activity and sensitizes DU145 prostate cancer cells to cisplatin
Homologous recombination HR, DU145 Prostate cancer, Chemoresistance, DNA double-strand breaks, DU145 prostate cancer, 0, RAD51 modulator, Cisplatin
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 1065962
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.